Santen Pharmaceutical Co., Ltd. (SNPHY)
10.69
-0.13
(-1.20%)
USD |
OTCM |
May 08, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 3.439B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 7.22% |
| Valuation | |
| PE Ratio | 17.48 |
| PE Ratio (Forward) | |
| PS Ratio | 1.855 |
| Price to Book Value | 1.902 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.1276 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 69.08% |
Profile
| Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan. |
| URL | http://www.santen.co.jp |
| Investor Relations URL | https://www.santen.com/en/ir/ |
| HQ State/Province | Osaka |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | May. 12, 2026 |
| Last Earnings Release | Feb. 05, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 27, 2018 |
Profile
| Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan. |
| URL | http://www.santen.co.jp |
| Investor Relations URL | https://www.santen.com/en/ir/ |
| HQ State/Province | Osaka |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | May. 12, 2026 |
| Last Earnings Release | Feb. 05, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 27, 2018 |